DR.NOAH BIOTECH's AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 ...
DR.NOAH BIOTECH received FDA approval for the IND application for a Phase 1 clinical trial of NDC-011, a new drug combination for ALS, developed using their AI platform ARK.
Reference News
DR.NOAH BIOTECH's AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 ...
DR.NOAH BIOTECH received FDA approval for the IND application for a Phase 1 clinical trial of NDC-011, a new drug combination for ALS, developed using their AI platform ARK.